Boston Scientific, a manufacturer of medical devices used in interventional medical specialties, agreed to acquire Silk Road Medical, a medical device company that is focused on reducing the risk of stroke, for $1.26bn. "The TCAR platform developed by Silk Road Medical is a notable advancement in the field of vascular medicine, which has revolutionized stroke prevention and the treatment of carotid artery disease. We believe the addition of this clinically differentiated technology to our vascular portfolio demonstrates our continued commitment to provide meaningful innovation for physicians who care for patients with peripheral vascular disease," Cat Jennings, Boston Scientific President.